therapeutic effects of sulphasalazine in ulcerative colitis and crohn 's disease correlate with serum concentrations of total sulphapyridine ( 20 to 50 microng/ml ) , and toxicity with total sulphapyridine concentration greater than 50 microng/ml .
C0036078
sulphasalazine
C0009324
ulcerative colitis